Korean J Urol. 2012 Feb;53(2):134-136. English.
Published online Feb 20, 2012.
© The Korean Urological Association, 2012
Case Report

Myotonic Dystrophy Type 1 Presenting as Male Infertility

Woong Bin Kim, Ji Yun Jeong, Seung Whan Doo, Won Jae Yang, Yun Seob Song, Seung Ryul Lee,1 Ji Woong Park,1 and Dong Won Kim2
    • Department of Urology, Soonchunhyang University Seoul Hospital, Soonchunhyang University College of Medicine, Seoul, Korea.
    • 1Department of Physical and Rehabilitation Medicine, Soonchunhyang University Seoul Hospital, Soonchunhyang University College of Medicine, Seoul, Korea.
    • 2Department of Pathology, Soonchunhyang University Seoul Hospital, Soonchunhyang University College of Medicine, Seoul, Korea.
Received July 12, 2011; Accepted August 17, 2011.

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

Myotonic dystrophy 1 (DM1) is a multi-system disorder characterized by endocrine defects that include testicular and tubular atrophy, oligospermia and azoospermia, and increased follicle-stimulating hormone levels. We describe a rare case of DM1 presenting as infertility in a 29-year-old man.

Keywords
Infertility; Myotonic dystrophy

Myotonic dystrophy 1 (DM1) is defined as a hereditary, autosomal dominant multi-system disorder characterized by the development of structural and functional abnormalities in the muscle membrane protein associated with muscular dystrophy, cardiac conduction disorders, cataracts, mental retardation, and endocrine and reproductive defects [1]. The genetic mutation in DM1 is the expansion of a CTG repeat sequence found in the 3'-untranslated region of the myotonic dystrophy protein kinase (DMPK) gene located on chromosome 19q13.3 [2, 3]. Reproductive abnormalities are a well-recognized finding in DM1. Progressive testicular atrophy is a prominent feature and occurs with an incidence of approximately 80%. Histological abnormalities include hyalinization, atrophy, fibrosis of seminiferous tubules, and reduced sperm numbers [1]. Oligospermia and azoospermia are reported in approximately 73% of DM1 patients [4]. Herein, we report a case of a patient with azoospermia associated with DM1 and review the literature.

CASE REPORT

A 29-year-old man was seen in our clinic over a 2-year duration for infertility. His medical history did not include cryptorchidism, herniorrhaphies, orchitis, mumps, or drug ingestion. He appeared healthy, and his height and body weight were 171 cm and 70 kg, respectively. However, the patient complained of progressive, mild distal extremities weakness for the past 3 years. He could not endure a heavy burden of more than 10 kg. The physical exam revealed soft, atrophied testicle on palpation, measuring 5 ml, bilaterally, with preserved epididymis and vas. The size of the penis and pubic hair growth were unremarkable. He did not complain of any erectile problems. Neurologic examination demonstrated 4-4+/5 strength at the proximal extremities and 3-3+/5 strength at the distal extremities. Semen analysis performed 2 times after an appropriate abstinence period demonstrated a low ejaculate volume (<1 ml) with azoospermia. Post-ejaculate urinalysis also showed no sperm. Endocrine evaluation revealed a plasma leutenizing hormone level of 2.97 mIU/ml (0.4 to 5.7) and testosterone level of 668.80 ng/ml (241 to 827), but his plasma follicle stimulating hormone level was elevated at 30.33 mIU/ml (1.1 to 13.5). A testicular biopsy was performed given concerns for primary testicular failure. The biopsy results revealed hypospermatogenesis (Fig. 1A), atrophy, and marked hyalization of the seminiferous tubules (Fig. 1B). Needle electromyography demonstrated an early interference pattern and myotonic discharge at the distal extremities, which is a pathognomonic finding for DM1 (Fig. 2). Gene analysis revealed an expansion of the CTG repeat sequence of up to 833 copies, thus confirming classic DM1. The patient was informed that having a baby might be possible by intracytoplasmic sperm injection (ICSI); however, it would result in the heritable disease among his offspring.

FIG. 1
(A) Testicular biopsy revealed hypospermatogenesis (H&E, ×100), (B) atrophy, and marked hyalization of the seminiferous tubules (H&E, ×400).

FIG. 2
Needle electromyography demonstrated myotonic discharge at the distal extremities.

DISCUSSION

DM1 is the most common cause of an inherited, adult-onset, muscular dystrophy [5]. Symptoms include muscle atrophy, cataracts, male infertility, and endocrinopathies. The disease is caused by an expansion of an unstable CTG trinucleotide repeat on chromosome 19q13.3 of a gene that codes for a serine-threonine kinase. The size of the unstable repeat appears to be related to the age at onset and to the severity of the disease; the largest repeat sizes are seen in persons with congenital DM1 [5]. In the normal population, the number of CTG repeats is polymorphic, ranging from 5 to 37 copies [3]. A minimal amplification of the repeat, ranging from 42 to 80 copies, designates mild DM1, which is characterized by no or only mild manifestations of the disease. In classic DM1, the copy number of CTG repeats is usually >80, which causes a more severe phenotype [6]. Our patient had 833 copies and belonged to this category.

To our knowledge, this is the first case of male infertility associated with DM1 in Korea. Although there are no data on the prevalence of DM1 in Korea, the Japanese, an ethnicity similar to Koreans, have a comparable or higher prevalence of DM1 (5.5/100,000) compared with West Europeans (2.5 to 5.5/100,000) [7]. Reproductive abnormalities are a well-recognized finding in DM1. Nearly two thirds of men have testicular atrophy and many will have oligospermia or azoospermia [5]. Although ICSI has become a powerful technology for men with various spermatogenic disorders to increase their prospects of parenthood, genetic consultation with these infertile patients is of great concern. Recent studies have suggested that many of the so-called idiopathic azoospermia may have a genetic basis [8]. It has been proposed that larger CTG repeat alleles in the DMPK gene might be associated with idiopathic azoospermia [9]. This implies that some patients with idiopathic azoospermia may be carriers of larger trinucleotide repeat alleles, ultimately leading to increased incidences of heritable diseases among their offspring [9]. Genetic diseases that do not primarily affect the genitourinary tract may have hidden urologic manifestations such as infertility. Thus, the practicing urologist should have knowledge of these diseases.

Notes

The authors have nothing to disclose.

References

    1. Sarkar PS, Paul S, Han J, Reddy S. Six5 is required for spermatogenic cell survival and spermiogenesis. Hum Mol Genet 2004;13:1421–1431.
    1. Mahadevan M, Tsilfidis C, Sabourin L, Shutler G, Amemiya C, Jansen G, et al. Myotonic dystrophy mutation: an unstable CTG repeat in the 3' untranslated region of the gene. Science 1992;255:1253–1255.
    1. Brook JD, McCurrach ME, Harley HG, Buckler AJ, Church D, Aburatani H, et al. Molecular basis of myotonic dystrophy: expansion of a trinucleotide (CTG) repeat at the 3' end of a transcript encoding a protein kinase family member. Cell 1992;68:799–808.
    1. Klesert TR, Otten AD, Bird TD, Tapscott SJ. Trinucleotide repeat expansion at the myotonic dystrophy locus reduces expression of DMAHP. Nat Genet 1997;16:402–406.
    1. Kolettis PN. Genetic disease in adults. Urol Clin North Am 2003;30:153–160.
    1. Brewster B, Groenen P, Wieringa B. Myotonic dystrophy: clinical and molecular aspects. In: Emery AEH, editor. Neuromuscular disorders: clinical and molecular genetics. Chichester: John Wiley & Sons Ltd; 1998. pp. 323-364.
    1. Davies J, Yamagata H, Shelbourne P, Buxton J, Ogihara T, Nokelainen P, et al. Comparison of the myotonic dystrophy associated CTG repeat in European and Japanese populations. J Med Genet 1992;29:766–769.
    1. Mifsud A, Sim CK, Boettger-Tong H, Moreira S, Lamb DJ, Lipshultz LI, et al. Trinucleotide (CAG) repeat polymorphisms in the androgen receptor gene: molecular markers of risk for male infertility. Fertil Steril 2001;75:275–281.
    1. Pan H, Li YY, Li TC, Tsai WT, Li SY, Hsiao KM. Increased (CTG/CAG)(n) lengths in myotonic dystrophy type 1 and Machado-Joseph disease genes in idiopathic azoospermia patients. Hum Reprod 2002;17:1578–1583.

Metrics
Share
Figures

1 / 2

PERMALINK